To further verify whether cell sensitivity to FAK or Src inhibitors was associated with COL4A1 expression, we examined cell sensitivity to those two inhibitors after modulating COL4A1 expression in HCC cells. This evidence concerns the gene SRC and hepatocellular carcinoma.